Company Filing History:
3 out of 165 
1 out of 3,578 
1 out of 425 
Years Active: 2009-2018
Title: The Innovative Journey of Patricia Greenhalgh
Introduction: Patricia Greenhalgh, an esteemed inventor based in Bedford, MA, has made significant contributions to the field of biotechnology with a total of five patents to her name. Her inventive spirit and dedication to improving health and safety through innovative methods have established her as a noteworthy figure in her field.
Latest Patents: Greenhalgh's recent work focuses on critical advancements in virus removal and cancer treatment. One of her latest inventions, "Method of determining virus removal from a sample containing a target protein using activated carbon," provides cutting-edge methods designed to assess the efficacy of activated carbon in removing viruses from protein-containing samples. Another significant patent, "Modified CEA nucleic acid and expression vectors," relates to a nucleic acid that encodes a polypeptide, which can be instrumental in preventing and treating cancer. It also discusses improved vectors for the insertion and expression of foreign genes, particularly those encoding tumor antigens for immunotherapeutic applications.
Career Highlights: Throughout her career, Greenhalgh has worked with prominent organizations, including Sanofi Pasteur Inc. and the United States Department of Health and Human Services. Her tenure at these institutions has enabled her to develop innovative solutions addressing some of the most pressing health challenges.
Collaborations: Patricia has collaborated with notable professionals in her field, including Linda R. Gritz and Mark Parrington. Their teamwork and shared expertise have contributed to the successful development of her patents and advancements in biotechnology.
Conclusion: Patricia Greenhalgh’s journey as an inventor underscores the importance of innovation in tackling significant health issues. Through her patented inventions, she continues to pave the way for future developments in virology and cancer treatment, and her contributions are likely to have a lasting impact on the industry.